This article is more than 5 years old. Information may no longer be current.

Bausch & Lomb signs agreement to use Phase Forward InForm system in clinical trials

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WALTHAM, Mass. — Bausch & Lomb has entered into a multi-year contract with Phase Forward, with plans to implement the company's InForm Global Trial Management electronic data capture solution in all of Bausch & Lomb's clinical trials, according to a press release.

"Bausch & Lomb is committed to the use of innovative technology to help develop the highest quality eye health products in the most efficient manner," John W. Sheets Jr., corporate vice president and chief technology officer, Bausch & Lomb, said in the release. "Clinical trials are a critical element of our product development engine, and Phase Forward's [electronic data capture] solution brings a proven solution for automating and optimizing trial management."

The InForm system includes the Central Coding module, which will automate Bausch & Lomb's surgical, vision care and pharmaceutical product trials. The module will help to "streamline the process of coding medical terms for trials, automating manual tasks while increasing coding consistency and accuracy," the release said.